LANTHEUS MEDICAL's Complete FDA Record

FDA action counts

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. LANTHEUS MEDICAL has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Enforcement history

On 2026-09-21, Argus HQ recorded an FDA approval for LANTHEUS MEDICAL, rated "info" severity in Argus HQ's classification: LANTHEUS MEDICAL — ANDA approval: BRAVNETSA (unspecified). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Frequently asked questions

How many FDA actions does Argus HQ track for LANTHEUS MEDICAL?

1 total: 0 warning letters, 0 recalls, 1 approval record, and 0 Form 483 inspection citations.

What is the most recent FDA action on file for LANTHEUS MEDICAL?

September 21, 2026. Argus HQ ingests new FDA enforcement records daily.

Is this FDA enforcement data for LANTHEUS MEDICAL official?

Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.

How many FDA actions has LANTHEUS MEDICAL had?

Argus HQ has recorded 1 FDA events for LANTHEUS MEDICAL: 0 warning letters, 0 recalls, 1 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Related enforcement actions

• LANTHEUS MEDICAL — ANDA approval: BRAVNETSA (unspecified) →

Compare with

• LANTHEUS MEDICAL vs Philips North America
• LANTHEUS MEDICAL vs Medline Industries, LP
• LANTHEUS MEDICAL vs Boston Scientific Corporation
• LANTHEUS MEDICAL vs Baxter Healthcare Corporation
• LANTHEUS MEDICAL vs PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.